SCHEMBL13159477

SCHEMBL13159477

C=C(C(=O)OC(C)(C)CCOCc1cccc2ccccc12)C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
PARP10 Q53GL7 1/20 0.36
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36
SLC1A1 P43005 1/20 0.36
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 3/20 0.35
ACP3 P15309 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
FFAR1 O14842 1/20 0.34
AKR1B1 P15121 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MAPK8 P45983 1/20 0.34
MAPK9 P45984 1/20 0.34
MAPK10 P53779 1/20 0.34
EPHX1 P07099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13159534 0.88 ATM (0.35) ATMKMT2AMEN1PARP10SLC1A3
SCHEMBL13159403 0.87 MEN1 (0.41) ATMKMT2AMEN1PARP10SLC1A3
SCHEMBL13159459 0.82 KDM4E (0.49) ATMKMT2AHPGDTDP1KDM4E
SCHEMBL13159370 0.79 PPARG (0.36) ATMKMT2AMEN1SLC1A3SLC1A2
SCHEMBL13159461 0.77 LTB4R (0.33) KMT2AMEN1HPGDTDP1KDM4E
SCHEMBL13159476 0.77 CASP1 (0.35) ATMKMT2AHPGDKDM4EALDH1A1
SCHEMBL13159468 0.77 CDC25B (0.37) ATMKMT2AHPGDTDP1KDM4E
SCHEMBL13159596 0.76 MEN1 (0.39) ATMKMT2AMEN1PARP10SLC1A3
SCHEMBL13159464 0.76 GPR84 (0.38) HPGDKDM4EALDH1A1
SCHEMBL13159465 0.74 KDM4E (0.33) KMT2AMEN1HPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8808960-B2 Compound and chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-08-19 US disclosed
US-8808960-B2 Compound and chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-08-19 US disclosed
US-20100233628-A1 COMPOUND AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-16 US disclosed
US-20100233628-A1 COMPOUND AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100233628-A1 COMPOUND AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION HRH3, C9, H1-2 ATM 2632/4885KMT2A 666/4885MEN1 932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.